Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration
Decibel Cannabis Raises $1.18M, Secures Capital For AgMedica BioScience Integration
Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) has completed the second and final closing of its previously announced non-brokered private placement of its common shares at $0.06 per common share.
Decibel大麻股公司（tsxv:db）（otcqb:dbccf）已经完成其之前宣布的无中介定向增发的第二轮和最终轮，发行价格为每股0.06美元。
What Happened
发生了什么
The company said on Monday that, at the second closing of the offering, it issued 19,647,776 common shares for gross proceeds of roughly $1,178,867.
该公司在周一表示，在此次发行的第二次闭合中，发行了19,647,776股普通股，筹集的毛利率大约为1,178,867美元。
The second closing was in addition to the previously announced first closing in November when Decibel issued 33,503,864 common shares for gross proceeds of approximately $2,010,232.
第二次闭合是之前在11月宣布的第一次闭合的补充，当时Decibel发行了33,503,864股普通股，筹集的毛利率约为2,010,232美元。
Read Also: Decibel's $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio
另请阅读：Decibel的1000万策略：它如何增强你的加拿大大麻股投资组合
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.
- 订阅本新闻快讯，每天免费获取Benzinga独家分析和大麻股行业及市场的最新资讯。如果您对业务认真，不容错过。在这里订阅我们的新闻简报。
Why It Matters
这为以下原因非常重要
Decibel said the proceeds of the offering will be used to work on and help integrate the integration of AgMedica BioScience Inc. which he company previously acquired. The acquisition was arranged through an agreement with Callisto Capital on Oct. 28 and was made in exchange for a $6.3 million unsecured convertible debenture.
Decibel表示，本次发行的收益将用于开发并帮助整合公司之前收购的AgMedica BioScience Inc.。该收购是通过与Callisto Capital于10月28日达成的协议安排的，作为交换，发放了一份630万无担保可转换债券。
Decibel projects that AgMedica could contribute $30 million of net revenue and $4 million of EBITDA in 2025, totaling an anticipated $130 million of net revenue and $25 million of adjusted EBITDA in 2025 on a pro forma basis.
Decibel预计AgMedica在2025年将贡献3000万美元的净营业收入和400万美元的EBITDA，从而预计2025年的净营业收入总额为13000万美元，调整后EBITDA为2500万美元。
The company recently announced its unaudited interim financial results on Thursday for the third quarter revealing CA$24.1 million ($17.2 million) in net revenue representing a 9% increase sequentially, but a 12% decrease year-over-year. However, gross margin before fair value adjustments reached 53% for the period, up from 44% in the prior year's period, reflecting improved operational efficiency.
该公司最近在周四公布了未经审计的第三季度 interim financial results，显示净营业收入为2410万加元（1720万美元），环比增长9%，同比下降12%。然而，在公允价值调整前的毛利率在该期间达到了53%，高于去年同期的44%，反映出运营效率的改善。
What's Next
接下来怎么做
The offering is subject to the receipt of all regulatory approvals including the final approval of the TSX Venture Exchange (TSXV).
该发行须获得所有监管批准，包括tsxv的最终批准。
Now Read:
现在就阅读吧:
- Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches
- Decibel大麻股报告第二季度净营业收入同比下降22%，计划通过新产品发布获益。
DBCCF Price Action
DBCCF价格动态
Decibel's shares traded 1.45% higher at $0.0476 per share after the market close on Friday afternoon.
Decibel的股票在周五下午市场收盘后上涨1.45%，每股交易价为0.0476美元。
